Origin of ovarian cancer may have implications for screening.
Tuma
Rabiya S
RS
D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood; D018284:Cystadenocarcinoma, Serous / Q000175:diagnosis / Q000209:etiology; D005185:Fallopian Tube Neoplasms / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000401:mortality / Q000556:secondary; D011230:Precancerous Conditions / Q000175:diagnosis*; D014463:Ultrasonography
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen